DESANTIS, JENNY
 Distribuzione geografica
Continente #
NA - Nord America 486
EU - Europa 351
AS - Asia 212
AF - Africa 1
Totale 1.050
Nazione #
US - Stati Uniti d'America 486
IE - Irlanda 112
VN - Vietnam 102
IT - Italia 94
HK - Hong Kong 69
SE - Svezia 31
CN - Cina 26
BE - Belgio 25
RU - Federazione Russa 18
DE - Germania 15
FI - Finlandia 15
FR - Francia 12
GB - Regno Unito 5
UA - Ucraina 5
IN - India 4
JP - Giappone 4
PL - Polonia 4
CH - Svizzera 3
NL - Olanda 3
BG - Bulgaria 2
RO - Romania 2
SG - Singapore 2
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
ID - Indonesia 1
KR - Corea 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MC - Monaco 1
PK - Pakistan 1
UZ - Uzbekistan 1
Totale 1.050
Città #
Chandler 186
Dublin 112
Dong Ket 100
Hong Kong 66
San Mateo 39
Perugia 32
Brussels 25
Altamura 23
Lawrence 21
Medford 21
Princeton 21
Beijing 19
Wilmington 11
West Jordan 10
Andover 9
Fremont 8
Helsinki 8
Los Angeles 6
Saint Petersburg 6
Chicago 5
Norwalk 5
Redwood City 4
Spoleto 4
Des Moines 3
Redmond 3
San Paolo di Civitate 3
Siena 3
Vigodarzere 3
Arezzo 2
Boardman 2
Campegine 2
Den Haag 2
Fairfield 2
Indore 2
Kagoya 2
Lappeenranta 2
Monza 2
Moscow 2
New York 2
Pozzuoli 2
Shanghai 2
Tappahannock 2
Zhengzhou 2
Abidjan 1
Absecon 1
Anguillara Sabazia 1
Ann Arbor 1
Bollebygd 1
Budapest 1
Casoria 1
Esslingen am Neckar 1
Hangzhou 1
Hanoi 1
Hanover 1
Ho Chi Minh City 1
Houston 1
Jakarta 1
Krimpen Aan Den Ijssel 1
Luxembourg 1
Milan 1
Monaco 1
Nuremberg 1
Pasadena 1
Philadelphia 1
Pitesti 1
Rome 1
San Giustino 1
San Jose 1
Seoul 1
Sovicille 1
Timisoara 1
Tokyo 1
Vaduz 1
Zurich 1
Totale 817
Nome #
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 178
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 64
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 63
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 62
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 54
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 54
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 53
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 53
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 50
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 44
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 43
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications 39
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 37
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 31
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 31
CROMATIC: Cross-Relationship Map of Cavities from Coronaviruses 30
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 30
Effects of MTX-23, a novel PROTAC of androgen receptor splice variant-7 and androgen receptor, on CRPC resistant to second-line antiandrogen therapy 29
PROTACs bearing piperazine-containing linkers: what effect on their protonation state? 28
Automatic Identification of Lansoprazole Degradants under Stress Conditions by LC-HRMS with MassChemSite and WebChembase 28
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 26
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 26
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 26
Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV 17
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design 14
Proteolysis targeting chimeras in antiviral research 13
MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib 10
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 8
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis 7
VHL-Modified PROteolysis TArgeting Chimeras (PROTACs) as a Strategy to Evade Metabolic Degradation in In Vitro Applications 3
Totale 1.151
Categoria #
all - tutte 4.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.993


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 2 7
2019/202052 2 0 4 0 2 2 10 3 2 26 1 0
2020/2021192 0 16 2 1 37 7 10 1 12 2 2 102
2021/2022176 5 27 2 9 3 1 3 45 20 5 34 22
2022/2023479 22 100 16 49 36 50 0 27 158 2 16 3
2023/2024189 11 41 10 9 5 7 61 3 14 27 1 0
Totale 1.151